InternationalUSRemember you can easily switch between MIP US and MIP International at any time

The fine line between abuse and fair use at the PTAB

Michael Loney, New York


Hedge fund manager Kyle Bass has outraged the pharma and biotech industries by seeking to invalidate their patents at the PTAB, with some observers linking his attacks to short-selling of company stocks. Michael Loney reports on a controversy that goes to the heart of the US patent system

Kyle Bass Roughly 700 Patent Trial and Appeal Board (PTAB) petitions had been filed in 2015 by May 20. Yet the story attracting the most interest for PTAB observers this year concerns a mere 2% of these.

Kyle Bass, who owns Dallas-based...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null null null

null null null

null

September / October 2019

Should I stay or should I go? Private practice v in-house

In-house or private practice? It’s a question many lawyers and attorneys will probably ask themselves at some stage in their career, as Managing IP finds out



Most read articles

Supplements